Published in Am J Psychiatry on December 01, 1996
Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input. Learn Mem (2002) 1.48
Neural correlates of probabilistic category learning in patients with schizophrenia. J Neurosci (2009) 1.12
Relative risk of probabilistic category learning deficits in patients with schizophrenia and their siblings. Biol Psychiatry (2010) 0.95
Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications. Psychopharmacology (Berl) (2004) 0.89
Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement. Psychopharmacology (Berl) (2004) 0.89
Mechanism-based pharmacokinetic-pharmacodynamic modeling of the dopamine D2 receptor occupancy of olanzapine in rats. Pharm Res (2011) 0.86
Factors associated with response to clozapine in schizophrenia: a review. Psychopharmacol Bull (2011) 0.82
Predictors and markers of clozapine response. Psychopharmacology (Berl) (2005) 0.82
In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.82
Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia. J Psychiatr Res (2016) 0.75
Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study. Psychopharmacology (Berl) (2013) 0.75
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A (2001) 9.42
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry (2005) 9.23
Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry (1987) 8.81
The intraclass correlation coefficient as a measure of reliability. Psychol Rep (1966) 7.27
Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature (1983) 5.80
The calcium current of Helix neuron. J Gen Physiol (1978) 5.18
Inactivation of calcium channels in mammalian heart cells: joint dependence on membrane potential and intracellular calcium. J Physiol (1985) 4.69
Rad53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpoint. Science (1998) 4.59
Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry (1986) 4.34
Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry (2000) 3.96
Molecular cloning, mapping, and regulation of Pho regulon genes for phosphonate breakdown by the phosphonatase pathway of Salmonella typhimurium LT2. J Bacteriol (1995) 3.94
Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet (1997) 3.77
Posterior instrumentation and anterior interbody fusion for tuberculous kyphosis of dorsal and lumbar spines. Spine (Phila Pa 1976) (1995) 3.77
MKK1 and MKK2, which encode Saccharomyces cerevisiae mitogen-activated protein kinase-kinase homologs, function in the pathway mediated by protein kinase C. Mol Cell Biol (1993) 3.54
Properties of internally perfused, voltage-clamped, isolated nerve cell bodies. J Gen Physiol (1978) 3.44
Reversal of current through calcium channels in dialysed single heart cells. Nature (1982) 3.43
Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex (2000) 3.37
On the methods and theory of reliability. J Nerv Ment Dis (1976) 3.35
Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex (1999) 3.31
Neonatal mortality: an analysis of the recent improvement in the United States. Am J Public Health (1980) 3.20
High selectivity of calcium channels in single dialysed heart cells of the guinea-pig. J Physiol (1984) 3.12
Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med (1990) 3.10
Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry (1990) 3.07
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A (1997) 3.00
Natural transmission of Plasmodium knowlesi to humans by Anopheles latens in Sarawak, Malaysia. Trans R Soc Trop Med Hyg (2006) 2.94
Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science (1998) 2.88
Education and change in cognitive function. The Epidemiologic Catchment Area Study. Ann Epidemiol (1995) 2.87
Cognitive effects of corticosteroids. Am J Psychiatry (1990) 2.85
Episodic multiregional cortical coherence at multiple frequencies during visual task performance. Nature (1993) 2.85
Sodium current in single rat heart muscle cells. J Physiol (1981) 2.83
Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry (2001) 2.80
The very low-birth-weight rate: Principal predictor of neonatal mortality in industrialized populations. J Pediatr (1980) 2.79
The subcellular basis for the mechanism of inotropic action of cardiac glycosides. Pharmacol Rev (1971) 2.78
Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet (1995) 2.72
Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry (2007) 2.70
Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol (1996) 2.68
Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry (2000) 2.66
A proposal for the classification of sigma binding sites. Trends Pharmacol Sci (1992) 2.65
Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry (2000) 2.62
Noise reduction in 3D perfusion imaging by attenuating the static signal in arterial spin tagging (ASSIST). Magn Reson Med (2000) 2.58
Guidelines for the recording and quantitative analysis of electroencephalographic activity in research contexts. Psychophysiology (1993) 2.57
Neurophysiological correlates of age-related changes in human motor function. Neurology (2002) 2.52
Optical, thermo-optic, electro-optic, and photoelastic properties of bismuth germanate (Bi(4)Ge(3)O(12)). Appl Opt (1996) 2.49
Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry (1997) 2.48
Idiopathic transverse myelitis: MR characteristics. AJNR Am J Neuroradiol (1996) 2.48
Thoracic sequelae and complications of tuberculosis. Radiographics (2001) 2.47
Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. 1993. Psychiatr Serv (2000) 2.43
Venoocclusive disease of the liver following bone marrow transplantation. Transplantation (1987) 2.35
Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry (2000) 2.34
A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry (2000) 2.32
Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry (2005) 2.29
Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology (2000) 2.28
Electrical impedance myography in the bedside assessment of inflammatory myopathy. Neurology (2005) 2.26
Srg3, a mouse homolog of yeast SWI3, is essential for early embryogenesis and involved in brain development. Mol Cell Biol (2001) 2.26
The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull (1974) 2.25
Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry (1987) 2.24
Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry (2006) 2.22
Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry (2010) 2.21
H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med (2000) 2.20
Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology (1997) 2.20
Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc Natl Acad Sci U S A (1997) 2.19
The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry (1987) 2.19
Sodium current in single heart muscle cells. Nature (1979) 2.19
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry (2003) 2.18
Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry (2007) 2.12
Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry (2001) 2.08
Schizophrenia and temporal lobe epilepsy. A neuropsychological analysis. Arch Gen Psychiatry (1994) 2.07
Essential function of the polo box of Cdc5 in subcellular localization and induction of cytokinetic structures. Mol Cell Biol (2000) 2.07
Relative risk of attention deficits in siblings of patients with schizophrenia. Am J Psychiatry (2000) 2.07
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry (2012) 2.07
New compensation method for bulk optical sensors with multiple birefringences. Appl Opt (1989) 2.04
Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer. Ann Oncol (2008) 2.03
Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet (1997) 2.02
Genetic contributions to regional variability in human brain structure: methods and preliminary results. Neuroimage (2002) 2.01
Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology (1993) 1.99
Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther (1982) 1.97
Lateral cerebral ventricular enlargement in chronic schizophrenia. Arch Gen Psychiatry (1979) 1.94
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry (2000) 1.93
Genetic variability of human brain size and cortical gyral patterns. Brain (1997) 1.92
Regulating ankyrin dynamics: Roles of sigma-1 receptors. Proc Natl Acad Sci U S A (2001) 1.92
Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. Aliment Pharmacol Ther (2010) 1.92
Reconstruction of the temporalis muscle for the pterional craniotomy. Technical note. J Neurosurg (1990) 1.91
Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol (1992) 1.91
Cognitive substrates of thought disorder, I: the semantic system. Am J Psychiatry (1998) 1.90
To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology (2000) 1.89
Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland. Arch Gen Psychiatry (1989) 1.89
Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood (1996) 1.88
NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology (1996) 1.88
Bronchial stenosis due to anthracofibrosis. Chest (1998) 1.87
A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol (2001) 1.86
Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology (1997) 1.86
Expression of androgen receptors in primary breast cancer. Ann Oncol (2009) 1.85
Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin Exp Res (2001) 1.85
Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry (2002) 1.81